Results of the 2022 global WHO online survey on diagnostic capacities and treatment practices for implantation (deep) mycoses

Barbara Milani (WHO consultant), under the guidance of Daniel Argaw Dagne (WHO Department of Control of Neglected Tropical Diseases [WHO/NTD]), Heather Stone (United States Food and Drug Administration [USFDA], Marco Schito (CURE Drug Repurposing Collaboratory),David Denning (Global Action Fund for Fungal Infections, Geneva, Switzerland), Roderick Hay (International Foundation for Dermatology, London, United Kingdom of Great Britain and Northern Ireland) and Kingsley Asiedu (WHO/NTD) are gratefully acknowledged for their advice on the conceptualization of the survey and the analysis of the results. Jose Antonio Ruiz Postigo (WHO/NTD) and Stephanie Jourdan (WHO/NTD) assisted in translating the survey tool. Junerlyn Farah Virrey Agua (WHO/NTD) designed the online version. 

In June 2022, the World Health Organization (WHO) launched a framework for integrated control and management of skin-related neglected tropical diseases (“skin NTDs”) that describes how mycetoma, chromoblastomycosis and other deep (implantation) mycoses including sporotrichosis should be addressed and integrated in interventions against skin NTDs and in broader primary health care.

Full details: